Christopher Yea, Chief Development Officer: KalVista Pharmaceuticals KALV Sell · Filed 23/11/21

Trade details

Type: Insider sale
Amount: $58,539.99
Shares · price: 7,113 sh · $8.23 a share
Held after: 46,046 sh
Stock: KalVista Pharmaceuticals KALV
Person: Christopher YeaChief Development Officer
Trade date: 23/11/20
Filed: 23/11/21
Days to filing: 1 days

Sold 13.4% of holdings

Share of holding sold: 13.4%

KalVista Pharmaceuticals trades, last 26 weeks

What else happened in KalVista Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/10/21~23/12/20

Christopher Yea's recent trades

Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$905.2K
33,800 sh
$905.2K
Filed 05/29
Traded 05/27
Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$52.6K
1,966 sh
$52.6K
Filed 05/27
Traded 05/26
Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$63.1K
2,358 sh
$63.1K
Filed 05/26
Traded 05/22
Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$29.7K
1,108 sh
$29.7K
Filed 05/19
Traded 05/18
Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$67.7K
4,347 sh
$67.7K
Filed 02/24
Traded 02/23